HTK solution cardioplegia in paediatric patients: a meta-analysis.

IF 1.3 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Thoracic and Cardiovascular Surgeon Pub Date : 2024-11-05 DOI:10.1055/a-2461-3147
Lorhayne Kerley Capuchinho Scalioni Galvao, Ana Clara Felix de Farias Santos, Nicole Pimenta Dos Santos, Fernanda Valeriano Zamora, Belisa Brunow Ventura Biavatti, João Pedro Costa Esteves Almuinha Salles, Horbert Soares Mendonca
{"title":"HTK solution cardioplegia in paediatric patients: a meta-analysis.","authors":"Lorhayne Kerley Capuchinho Scalioni Galvao, Ana Clara Felix de Farias Santos, Nicole Pimenta Dos Santos, Fernanda Valeriano Zamora, Belisa Brunow Ventura Biavatti, João Pedro Costa Esteves Almuinha Salles, Horbert Soares Mendonca","doi":"10.1055/a-2461-3147","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Cardioplegia, a therapy designed to induce reversible cardiac arrest, revolutionised cardiovascular surgery. Among the various pharmacological approaches is the histidine-tryptophan-ketoglutarate (HTK) solution. Despite numerous studies, no meta-analysis has investigated the efficacy of the HTK solution in the paediatric population. Therefore, we aim to conduct a meta-analysis comparing HTK and other cardioplegia solutions in paediatric patients undergoing cardiovascular surgery.</p><p><strong>Methods: </strong>PubMed, Embase and Cochrane databases were searched from inception through April 2024. Endpoints were computed in odds ratios (OR) with 95% Confidence Intervals (CI) for dichotomous variables, whereas continuous variables were compared using mean differences (MD) with 95% CI.</p><p><strong>Results: </strong>11 studies comprising 1,349 patients were included, of whom 677 (50.19%) received HTK cardioplegia. The results were similar between groups regarding mortality (OR 0.98; 95% CI 0.29, 3.29), length of hospital (MD 0.32 days; 95% CI -0.88, 1.51), MV (MD -17.72 hours; 95% IC -51.29, 15.85), arrhythmias (OR 1.27; 95% CI 0.83, 1.95;) and delayed sternal closure (OR 0.89; 95% 0.56, 1.43). However, transfusion volume was lower in the HTK group (MD -452.39; 95% CI -890.24, -14.53; p=0.04).</p><p><strong>Conclusion: </strong>The use of HTK solution was demonstrated to be similar regarding its clinical efficacy to other approaches for cardioplegia, and it may present advantages to patients prone to hypervolemia.</p>","PeriodicalId":23057,"journal":{"name":"Thoracic and Cardiovascular Surgeon","volume":null,"pages":null},"PeriodicalIF":1.3000,"publicationDate":"2024-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Thoracic and Cardiovascular Surgeon","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1055/a-2461-3147","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Cardioplegia, a therapy designed to induce reversible cardiac arrest, revolutionised cardiovascular surgery. Among the various pharmacological approaches is the histidine-tryptophan-ketoglutarate (HTK) solution. Despite numerous studies, no meta-analysis has investigated the efficacy of the HTK solution in the paediatric population. Therefore, we aim to conduct a meta-analysis comparing HTK and other cardioplegia solutions in paediatric patients undergoing cardiovascular surgery.

Methods: PubMed, Embase and Cochrane databases were searched from inception through April 2024. Endpoints were computed in odds ratios (OR) with 95% Confidence Intervals (CI) for dichotomous variables, whereas continuous variables were compared using mean differences (MD) with 95% CI.

Results: 11 studies comprising 1,349 patients were included, of whom 677 (50.19%) received HTK cardioplegia. The results were similar between groups regarding mortality (OR 0.98; 95% CI 0.29, 3.29), length of hospital (MD 0.32 days; 95% CI -0.88, 1.51), MV (MD -17.72 hours; 95% IC -51.29, 15.85), arrhythmias (OR 1.27; 95% CI 0.83, 1.95;) and delayed sternal closure (OR 0.89; 95% 0.56, 1.43). However, transfusion volume was lower in the HTK group (MD -452.39; 95% CI -890.24, -14.53; p=0.04).

Conclusion: The use of HTK solution was demonstrated to be similar regarding its clinical efficacy to other approaches for cardioplegia, and it may present advantages to patients prone to hypervolemia.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
儿科患者的 HTK 溶液心脏麻痹:一项荟萃分析。
简介心脏麻痹是一种旨在诱导可逆性心脏停搏的疗法,它彻底改变了心血管外科手术。组氨酸-色氨酸-酮戊二酸(HTK)溶液是各种药理学方法中的一种。尽管有许多研究,但还没有一项荟萃分析调查了 HTK 溶液在儿科人群中的疗效。因此,我们旨在对接受心血管手术的儿科患者进行一项荟萃分析,比较 HTK 和其他心脏麻痹溶液:方法:检索了从开始到 2024 年 4 月的 PubMed、Embase 和 Cochrane 数据库。对于二分变量,终点以几率比(OR)和95%置信区间(CI)计算,而连续变量则以平均差(MD)和95%置信区间进行比较:结果:共纳入了 11 项研究,1,349 名患者,其中 677 人(50.19%)接受了 HTK 心脏麻痹。在死亡率(OR 0.98;95% CI 0.29,3.29)、住院时间(MD 0.32 天;95% CI -0.88,1.51)、MV(MD -17.72小时;95% IC -51.29,15.85)、心律失常(OR 1.27;95% CI 0.83,1.95;)和胸骨闭合延迟(OR 0.89;95% 0.56,1.43)方面,各组结果相似。然而,HTK 组的输血量较低(MD -452.39;95% CI -890.24,-14.53;P=0.04):结论:HTK溶液的临床疗效与其他心脏麻痹方法相似,对易发生高血容量的患者有一定优势。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
3.40
自引率
6.70%
发文量
365
审稿时长
3 months
期刊介绍: The Thoracic and Cardiovascular Surgeon publishes articles of the highest standard from internationally recognized thoracic and cardiovascular surgeons, cardiologists, anesthesiologists, physiologists, and pathologists. This journal is an essential resource for anyone working in this field. Original articles, short communications, reviews and important meeting announcements keep you abreast of key clinical advances, as well as providing the theoretical background of cardiovascular and thoracic surgery. Case reports are published in our Open Access companion journal The Thoracic and Cardiovascular Surgeon Reports.
期刊最新文献
HTK solution cardioplegia in paediatric patients: a meta-analysis. Intraoperative Invasive Coronary Angiography after Coronary Artery Bypass Grafting. Distal Events Following Emergent Operation for DeBakey Type I Aortic Dissection. Lactate Dehydrogenase Levels after aortic valve replacement: What do they tell us? Impact of High-Intensity Statin on Atrial Fibrillation After Off-Pump Coronary Artery Bypass.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1